Jill Nohl, APRN
Thoracic Surgery (Cardiothoracic Vascular Surgery) · Omaha, NENPI 1487175261
Payments from drug & device makers
What this record shows
4 manufacturers reported payments, led by Medtronic at 59.2% of the total. Reporting peaked in 2023 at $4,143 and has fallen 72.4% since, to $1,143 in 2025.
Across 110 payments — averaging $77.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$5K
- Abbott$3K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$148
- Abiomed$139
What the payments were for
- Travel & lodging$4,61154%
- Food & beverage$3,95346%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 40 | $5,067 |
| Abbott | 60 | $3,211 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 4 | $148 |
| Abiomed | 6 | $139 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,564 in reported general payments places this provider in the 60th percentile of 29 thoracic surgery (cardiothoracic vascular surgery) providers in Nebraska.
See all thoracic surgery (cardiothoracic vascular surgery) providers in Nebraska →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 58 | $42,661 |
| EntrestoSacubitril/Valsartan | 44 | $40,068 |
| Doxycycline Hyclate | 12 | $2,420 |
| Potassium Chloride | 51 | $2,246 |
| Enoxaparin Sodium | 17 | $1,712 |
| Warfarin Sodium | 249 | $1,640 |
| Torsemide | 36 | $647 |
| Metoprolol Succinate | 49 | $553 |
| Atorvastatin Calcium | 45 | $453 |
| Pantoprazole Sodium | 48 | $316 |
| Spironolactone | 46 | $203 |
| Amiodarone Hcl | 30 | $188 |
| Carvedilol | 24 | $174 |
| Tamsulosin Hcl | 16 | $126 |
| Losartan Potassium | 35 | $120 |
Paid to pharmacies, not to this prescriber.
Other thoracic surgery (cardiothoracic vascular surgery) in Omaha
- Helenmari MerrittOmaha$287K
- John BatterOmaha$29K
- Kim DuncanOmaha$23K
- David BerkheimOmaha$20K
- John UmOmaha$16K
- Karin TrujilloOmaha$16K
- Anthony CastleberryOmaha$16K
- Thomas LangdonOmaha$14K
- Marian UrbanOmaha$10K
- Rudy LacknerOmaha$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.